A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-Negative Breast Cancer
Interventions: DRUG: Camrelizumab|RADIATION: radiotherapy
Sponsor: Jiangxi Provincial Cancer Hospital